Vanguard Personalized Indexing Management, LLC Ascendis Pharma A/S Call Options Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ASND
# of Institutions
236Shares Held
58.2MCall Options Held
238KPut Options Held
299K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.22 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$647 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$629 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$556 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$528 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.03B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...